Multi-targeted protection of Yuping Tongqiao against allergic rhinitis: suppression of inflammatory response via TSLP signaling and reinforcement of epithelial barrier integrity via AhR signaling.
Saved in:
| Title: | Multi-targeted protection of Yuping Tongqiao against allergic rhinitis: suppression of inflammatory response via TSLP signaling and reinforcement of epithelial barrier integrity via AhR signaling. |
|---|---|
| Authors: | Wang Z; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China., Cai J; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China.; Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China., Wu J; Beijing University of Chinese Medicine School of Chinese Medicine, Beijing, China., Zheng H; Graduate School, Hebei Medical University, Shijiazhuang, China., Shi M; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China., Tong Y; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China., Hou Y; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China.; Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China.; Shanghai Yiling Pharmaceutical Co., Ltd., Shanghai, China., Jia Z; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China.; High-level TCM Key Disciplines of National Administration of Traditional Chinese Medicine - Luobing Theory, Hebei Yiling Hospital, Shijiazhuang, Hebei, China., Qi H; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China.; Graduate School, Hebei Medical University, Shijiazhuang, China. |
| Source: | Frontiers in allergy [Front Allergy] 2026 May 08; Vol. 7, pp. 1824120. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918227355906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2673-6101 (Electronic) Linking ISSN: 26736101 NLM ISO Abbreviation: Front Allergy Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42181850 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Multi-targeted protection of Yuping Tongqiao against allergic rhinitis: suppression of inflammatory response via TSLP signaling and reinforcement of epithelial barrier integrity via AhR signaling. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+Z%22">Wang Z</searchLink>; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China.<br /><searchLink fieldCode="AU" term="%22Cai+J%22">Cai J</searchLink>; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China.; Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; Beijing University of Chinese Medicine School of Chinese Medicine, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Zheng+H%22">Zheng H</searchLink>; Graduate School, Hebei Medical University, Shijiazhuang, China.<br /><searchLink fieldCode="AU" term="%22Shi+M%22">Shi M</searchLink>; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China.<br /><searchLink fieldCode="AU" term="%22Tong+Y%22">Tong Y</searchLink>; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China.<br /><searchLink fieldCode="AU" term="%22Hou+Y%22">Hou Y</searchLink>; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China.; Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China.; Shanghai Yiling Pharmaceutical Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Jia+Z%22">Jia Z</searchLink>; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China.; High-level TCM Key Disciplines of National Administration of Traditional Chinese Medicine - Luobing Theory, Hebei Yiling Hospital, Shijiazhuang, Hebei, China.<br /><searchLink fieldCode="AU" term="%22Qi+H%22">Qi H</searchLink>; State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang, Hebei, China.; Graduate School, Hebei Medical University, Shijiazhuang, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918227355906676%22">Frontiers in allergy</searchLink> [Front Allergy] 2026 May 08; Vol. 7, pp. 1824120. <i>Date of Electronic Publication: </i>2026 May 08 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9918227355906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2673-6101 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226736101%22">26736101 </searchLink><i>NLM ISO Abbreviation: </i>Front Allergy <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42181850 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/falgy.2026.1824120 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1824120 Titles: – TitleFull: Multi-targeted protection of Yuping Tongqiao against allergic rhinitis: suppression of inflammatory response via TSLP signaling and reinforcement of epithelial barrier integrity via AhR signaling. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang Z – PersonEntity: Name: NameFull: Cai J – PersonEntity: Name: NameFull: Wu J – PersonEntity: Name: NameFull: Zheng H – PersonEntity: Name: NameFull: Shi M – PersonEntity: Name: NameFull: Tong Y – PersonEntity: Name: NameFull: Hou Y – PersonEntity: Name: NameFull: Jia Z – PersonEntity: Name: NameFull: Qi H IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 05 Text: 2026 May 08 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2673-6101 Numbering: – Type: volume Value: 7 Titles: – TitleFull: Frontiers in allergy Type: main |
| ResultId | 1 |